PROKIDNEY CORP.
Extracted from this filing and checked against the source text.
PROKIDNEY CORP. shareholders approved Election of Directors for a three-year term expiring in 2026 at the 2023-06-29 meeting.
Based on the following results of the voting, the Company’s shareholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a three-year term to expire at the Company’s annual general meeting of shareholders in 2026 and until their successors are duly elected and qualified: Director Nominee For Against Abstain Broker Non Votes William F. Doyle 204,688,357 86,755 59,329 6,436,976 Alan M. Lotvin, M.D. 204,717,013 86,192 31,236 6,436,976 Brian J. G. Pereira, M.D. 204,658,435 84,994 91,012 6,436,976View on SEC.gov
PROKIDNEY CORP. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-29 meeting.
The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified based on the following results of the voting: For Against Abstain Broker Non Votes 211,255,952 15,231 234View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.